Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
808 studies found for:    Open Studies | "Head and Neck Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Optimal Tube Feeding Method in Head and Neck Cancer Patients
Condition: Head and Neck Cancer
Interventions: Procedure: Bolus;   Procedure: Gravity;   Device: Pump
22 Recruiting Couple-Based Intervention for Patients With Head and Neck Cancer and Their Partners
Condition: Head and Neck Cancer
Intervention: Behavioral: Couple-Based CBT Intervention
23 Recruiting PET With [18F]HX4 in Head and Neck Cancer
Condition: Cancer of the Head and Neck
Intervention: Procedure: Injection of [18F]HX4
24 Recruiting Adaptive Radiation Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatinum;   Radiation: Conventional radiotherapy;   Radiation: Adaptive radiotherapy
25 Recruiting Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)
Condition: Head and Neck Cancer
Intervention: Biological: Biomarker analyses head & neck cancer tissue, blood specimen
26 Recruiting Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)
Condition: Head and Neck Cancer
Interventions: Drug: Erbitux®;   Radiation: Fractionated Radiotherapy
27 Unknown  Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Radiation: Boron Neutron Capture Therapy
28 Recruiting Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Conditions: Head and Neck Cancer;   Mucositis
Interventions: Dietary Supplement: Glutamine;   Dietary Supplement: Placebo
29 Recruiting Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: LUZ11
30 Unknown  Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
Conditions: Head and Neck Cancer;   Surgery;   Nutrition;   Swallowing
Interventions: Behavioral: nutrition /swallowing counseling;   Behavioral: G-tube/swallowing intervention;   Behavioral: nutrition /swallowing intervention
31 Not yet recruiting Efficacy of EPA-enriched Supplement in Malnourished Head and Neck Cancer Patients Undergone Surgery
Condition: Head and Neck Cancer
Interventions: Dietary Supplement: EPA-enriched supplement;   Dietary Supplement: standard formula supplement
Condition: Head and Neck Cancer
Interventions: Radiation: Radiotherapy;   Drug: Leucovorin;   Biological: Cetuximab;   Drug: Filgrastim;   Drug: Erythropoetin;   Drug: Cisplatin;   Drug: Fluorouracil;   Drug: Docetaxel
33 Recruiting Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors
Condition: Head and Neck Cancer
Intervention: Radiation: DCE-MRI,  DW-MRI and MRS
34 Recruiting Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Biological: GX-051
35 Recruiting Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy
Condition: Head and Neck Cancer
Interventions: Device: bandage skin Hydrotac®;   Drug: Ialuset®
36 Recruiting Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer
Conditions: Head and Neck Cancer;   Oral Mucositis
Interventions: Dietary Supplement: Grape extract;   Drug: Lortab, Fentanyl patch, mouthwash
37 Recruiting Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab (associated with radiotherapy);   Drug: cisplatin (associated to radiotherapy)
38 Not yet recruiting Tissue and Hematopoietic Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
Conditions: Malignant Melanoma;   Head and Neck Cancer
Intervention: Drug: Filgrastim
39 Recruiting Preemptive Treatment With XONRID to Reduce Radiation Induced Dermatitis in Head and Neck Cancer Patients
Condition: Head and Neck Cancer
Intervention: Device: XONRID
40 Recruiting The Effect of Ganoderma on Patients With Head-and-neck Cancer
Condition: Head-and-neck Cancer
Interventions: Other: Control group;   Dietary Supplement: Ganoderma Spores Powder Capsules

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years